about
Most antidepressant use in primary care is justified; results of the Netherlands Study of Depression and AnxietyEpidemiology of psychotropic drug use in Rio de Janeiro, Brazil: gaps in mental illness treatmentsPsychotropic Drug Use in São Paulo, Brazil--An Epidemiological SurveyFrom descartes to desipramine: psychopharmacology and the self.Antidepressant adherence after psychiatric hospitalization among VA patients with depression.The evolving understanding of major depression epidemiology: implications for practice and policy.Creating groups with similar expected behavioural response in randomized controlled trials: a fuzzy cognitive map approach.Descriptive epidemiology of major depressive disorder in Canada in 2012.Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-AnalysisExploration of Undertreatment and Patterns of Treatment of Depression in Multiple Sclerosis.A Canadian Primary Care Sentinel Surveillance Network Study Evaluating Antidepressant Prescribing in Canada From 2006 to 2012.Self-reported indications for antidepressant use in a population-based cohort of middle-aged and elderlyRoutine screening for depression in patients with coronary heart disease never mind.Emerging drugs for major depressive disorder.The costs associated with antidepressant use in depression and anxiety in community-living older adults.Health services use for mental health problems by community-living seniors with depression.Antidepressant use and work-related injuries.Antidepressant use and associated factors among the elderly: the Bambuí Project.The impact of age and gender on adherence to antidepressants: a 4-year population-based cohort study.Antidepressant use among survivors of childhood, adolescent and young adult cancer: a report of the Childhood, Adolescent and Young Adult Cancer Survivor (CAYACS) Research Program.The impact of the type of insurance plan on adherence and persistence with antidepressants: a matched cohort study.Patterns of depressive symptoms and antidepressant use among women survivors of intimate partner violence.The utilization of antidepressants and benzodiazepines among people with major depression in Canada.Increase in antidepressant medication in the US adult population between 1990 and 2003.Frequency of antidepressant use in relation to recent and past major depressive episodes.Comorbidity of migraine and psychiatric disorders--a national population-based study.Correlates of antidepressant and anxiolytic, hypnotic or sedative medication use in an Australian community sample.Medication use and nonadherence to psychoactive medication for mental health problems by community-living Canadian seniors with depression.Optimism and pessimism as predictors of initiating and ending an antidepressant medication treatment.Antidepressant utilization patterns and mortality in Swedish men and women aged 20-34 years.Receiving guideline-concordant pharmacotherapy for major depression: impact on ambulatory and inpatient health service use.Prevalence of psychotropic use in a South Australian population.
P2860
Q28477553-A258771B-F950-4E0B-BC63-A465421BE95CQ28487993-A6C344E0-5438-40DC-AB11-FC2FE3C8F1DAQ28547129-310EFC3D-E563-4DFC-888F-A0D7FED01580Q30375614-D96293F4-3DAB-4728-AD0D-14A73741A0BAQ34135716-9F6E83D9-B932-4A2C-B9C6-8E057A0F2C5AQ34861619-6021B391-CF0E-427B-9C3E-5A73878C63C8Q34937857-03F019CD-153D-4E6B-B03F-5A4603FE16DFQ35038748-DBB3DDB0-F006-4718-85FB-42FFD4CD2758Q36123663-2CC460C1-42EF-4494-8008-7A083E2824E7Q36358378-D9DB7671-B934-4FB0-84EE-875D371AF963Q36371830-E6102488-BA55-4AA6-90C5-8B10B8740302Q37273446-4C9A6FE1-4A9F-427C-96A9-56CD4E0FBD59Q37358312-FC439290-CE8C-4C3C-80B9-2C58752AF8F7Q37564562-078A4957-76B9-48EF-9258-12EB730C33B6Q39441733-425C1FDD-4A92-4D1D-9322-12D745257288Q39815662-C9B2A232-0EF3-4FEB-8E79-E2E1F8611DA4Q40068322-FCB806BF-BFB3-442E-BB8D-B6CBC09088D5Q40183837-A866EF68-8441-4D0B-A5A9-9DDCBB0334D4Q40817256-AEA476A8-7D2F-472F-8326-1C6BC948F8C6Q43795259-C5DB68E1-84E6-402B-8A1E-75B878B2F9A0Q44240999-83C221C7-D6AD-40A1-8B2E-76093F6F7BA4Q45412458-DC5AEBC9-CA7F-4234-9470-6A3E544D35F3Q45912740-30BC2966-7D04-4AE9-9F52-13EA4294462CQ46784059-2BB08620-704E-49BB-818F-07614CC5F094Q46835175-74740208-35E4-4059-855A-27C565DB918DQ46857666-0F8F0A18-15DC-402B-8FBE-2DA8703E6236Q48310716-1BBA7D5E-E70B-4BB4-B0E4-2FA82E64241BQ48423104-7179E5B9-86A7-4CDD-990B-E0F9EBC61D43Q48547534-295DD4C1-D09E-45F0-B22B-5C1D1E7B6E5BQ48964678-0FACC2E2-AB16-49BB-B41A-6C4F1B942602Q51754232-3796EC53-1117-4324-978A-20DE118C8911Q51909944-C20373A7-4A58-4A16-BC44-C961AF77BB96
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Antidepressant utilization in Canada.
@en
Antidepressant utilization in Canada.
@nl
type
label
Antidepressant utilization in Canada.
@en
Antidepressant utilization in Canada.
@nl
prefLabel
Antidepressant utilization in Canada.
@en
Antidepressant utilization in Canada.
@nl
P2093
P1476
Antidepressant utilization in Canada.
@en
P2093
Colleen J Maxwell
Cynthia A Beck
Jeanne V A Williams
Jian Li Wang
Nady El-Guebaly
Shawn R Currie
P2860
P304
P356
10.1007/S00127-005-0968-0
P577
2005-10-01T00:00:00Z